Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,989 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial.
Einsele H, Engelhardt M, Tapprich C, Müller J, Liebisch P, Langer C, Kropff M, Mügge LO, Jung W, Wolf HH, Metzner B, Hart C, Gramatzki M, Hertenstein B, Pfreundschuh M, Rösler W, Fischer T, Maschmeyer G, Kanz L, Hess G, Jäger E, Bentz M, Dürk HA, Salwender H, Hebart H, Straka C, Knop S. Einsele H, et al. Among authors: muller j. Br J Haematol. 2017 Nov;179(4):586-597. doi: 10.1111/bjh.14920. Epub 2017 Sep 29. Br J Haematol. 2017. PMID: 28961309 Free article. Clinical Trial.
Bortezomib consolidation following autologous transplant in younger and older patients with newly diagnosed multiple myeloma in two phase III trials.
Straka C, Knop S, Vogel M, Müller J, Kropff M, Metzner B, Langer C, Sayer H, Jung W, Dürk HA, Salwender H, Wandt H, Bassermann F, Gramatzki M, Rösler W, Wolf HH, Brugger W, Fischer T, Liebisch P, Engelhardt M, Einsele H. Straka C, et al. Among authors: muller j. Eur J Haematol. 2019 Sep;103(3):255-267. doi: 10.1111/ejh.13281. Epub 2019 Jul 19. Eur J Haematol. 2019. PMID: 31231828 Clinical Trial.
Full or intensity-reduced high-dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma.
Straka C, Salwender H, Knop S, Vogel M, Müller J, Metzner B, Langer C, Sayer H, Jung W, Dürk HA, Bassermann F, Gramatzki M, Rösler W, Wolf HH, Brugger W, Engelhardt M, Fischer T, Liebisch P, Einsele H. Straka C, et al. Among authors: muller j. Eur J Haematol. 2021 Nov;107(5):529-542. doi: 10.1111/ejh.13690. Epub 2021 Aug 28. Eur J Haematol. 2021. PMID: 34270825
Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma.
Einsele H, Knop S, Vogel M, Müller J, Kropff M, Metzner B, Langer C, Sayer H, Jung W, Dürk HA, Salwender H, Wandt H, Bassermann F, Gramatzki M, Rösler W, Wolf HH, Brugger W, Engelhardt M, Fischer T, Liebisch P, Straka C. Einsele H, et al. Among authors: muller j. Leukemia. 2017 Jun;31(6):1463-1466. doi: 10.1038/leu.2017.83. Epub 2017 Mar 15. Leukemia. 2017. PMID: 28293022 No abstract available.
Evidence for a graft-versus-tumor effect in refractory ovarian cancer.
Hänel M, Bornhäuser M, Müller J, Thiede C, Ehninger G, Kroschinsky F. Hänel M, et al. Among authors: muller j. J Cancer Res Clin Oncol. 2003 Jan;129(1):12-6. doi: 10.1007/s00432-002-0399-1. Epub 2003 Jan 28. J Cancer Res Clin Oncol. 2003. PMID: 12618895
Development and Discovery of a Selective Degrader of Casein Kinases 1 δ/ε.
Haag A, Němec V, Janovská P, Bartošíková J, Adhikari B, Müller J, Schwalm MP, Čada Š, Ohmayer U, Daub H, Kim Y, Born F, Wolf E, Bryja V, Knapp S. Haag A, et al. Among authors: muller j. J Med Chem. 2024 Dec 27. doi: 10.1021/acs.jmedchem.4c02201. Online ahead of print. J Med Chem. 2024. PMID: 39729064
Predicting cisplatin tolerability in older adults with head and neck cancer - Insights for improved chemoradiation outcomes.
Rühle A, Weymann M, Behrens M, Olbrich J, Kut C, Marschner SN, Haderlein M, Fabian A, Senger C, Bakst BP, Kraft J, von der Grün J, Looman EL, Chen E, Domschikowski J, Altay-Langguth A, Kalinauskaite G, Lewitzki V, Bonomi M, Blakaj D, Jhawar SR, Baliga S, Elguindy ANMH, Ferentinos K, Zamboglou C, Müller JA, Leucht C, Dickstein DR, Schnellhardt S, Haehl E, Hambsch P, Kuhnt T, Seidel C, Belka C, Mayer A, Schmidberger H, Grosu AL, Balermpas P, Stromberger C, Binder H, Quon H, Nicolay NH. Rühle A, et al. Among authors: muller ja. Radiother Oncol. 2024 Dec 24:110697. doi: 10.1016/j.radonc.2024.110697. Online ahead of print. Radiother Oncol. 2024. PMID: 39725066
School-entry age and academic difficulties at 7 years of age in children born very preterm: A call for age-corrected schooling: School-entry age and academic difficulties at 7 years of age in children born very preterm.
Roze JC, Apprioual G, Morgan AS, Muller JB, Marret S, Rouger V, Leduc G, Benallegue N, Dinonais M, Bouvard C, Ancel PY, Flamant C. Roze JC, et al. Among authors: muller jb. Arch Pediatr. 2024 Dec 22:S0929-693X(24)00212-4. doi: 10.1016/j.arcped.2024.10.007. Online ahead of print. Arch Pediatr. 2024. PMID: 39718477
Head-to-Head Comparison of Learning Curves Between QFR and FFRangio Software Users.
Salihu A, Zulauff J, Gadiri MA, Metzinger A, Muller J, Skalidis I, Meier D, Noirclerc N, Mauler-Wittwer S, Zimmerli A, Muller O, Fournier S. Salihu A, et al. Among authors: muller j. Catheter Cardiovasc Interv. 2024 Dec 24. doi: 10.1002/ccd.31384. Online ahead of print. Catheter Cardiovasc Interv. 2024. PMID: 39718047
6,989 results